The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic pathways and disease associations without systematic search methodology
PubMed 38275657 · doi:10.3390/antiox13010132
What was done
The authors synthesized literature on the biological mechanisms of neutrophil-derived myeloperoxidase (MPO), specifically its catalytic production of hypochlorous acid (HOCl) from chloride and hydrogen peroxide. They reviewed MPO's role across cardiovascular diseases, neurodegenerative diseases, cancers, renal diseases, and lung diseases (including COVID-19), alongside experimental evidence on MPO deficiency and pharmacological inhibition.
What was found
The abstract reports no quantitative metrics or effect sizes. It describes that MPO-derived oxidants contribute to disease pathogenesis primarily through the oxidation of biomolecules, driving inflammation and oxidative stress, while MPO deficiency or inhibitor use attenuates inflammation and tissue injury.
Why it matters
This review synthesizes cross-disease mechanistic pathways of neutrophil-mediated oxidative damage, framing MPO as a potential candidate for prognostic biomarkers and anti-inflammatory drug development.
Limits
As a narrative review, it lacks a systematic literature search, inclusion/exclusion criteria, and risk-of-bias evaluation. No quantitative clinical data or sample sizes are reported in the abstract, and the described mechanisms rely heavily on preclinical models.
Cited by
- supports Neutrophils release the enzyme myeloperoxidase (MPO), which produces hypochlorite (bleach) outside the cell, as well as proteases.